申请人:Ye Keqiang
公开号:US20130158082A1
公开(公告)日:2013-06-20
The disclosure relates to methods of managing blood sugar levels and compositions related thereto. In certain embodiments, the disclosure relates to methods of treating or preventing diabetes, insulin resistance, or hyperglycemia comprising administering to a subject diagnosed with, at risk of or exhibiting symptoms of diabetes, insulin resistance, or hyperglycemia a pharmaceutical composition comprising a compound comprising formula I.
本公开涉及管理血糖水平的方法及相关组合物。在某些实施例中,本公开涉及治疗或预防糖尿病、胰岛素抵抗或高血糖的方法,包括向被诊断为、处于风险中或表现出糖尿病、胰岛素抵抗或高血糖症状的受试者施用含有式I化合物的制药组合物。